Hyloris Pharmaceuticals Stock Quote 0AB6 - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

28,000,000

Dividend Yield

PE Ratio

-10.56

Earnings Per Share (EPS)

-0.55

Revenue

4.21M

Net Profit

-15.38M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hyloris.com

Headquarters

Liege, Liege, Bel

Founded

Hyloris Pharmaceuticals Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0AB6. The last closing price for Hyloris Pharmaceuticals was -. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 0.00 € to 0.00 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -10.56.

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures Innovative oral care solution aims to benefit...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires Une...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EMLEmmerson Plc	0.825p (98.80%)	116.5M
UOGUnited Oil & Gas Plc	0.265p (65.63%)	240.97M
CATCatco Reinsurance Opportunities Fund Limited	$ 37.50 (50.00%)	4k
NTOGNostra Terra Oil And Gas Company Plc	0.0425p (30.77%)	145.55M
RRRRed Rock Resources Plc	0.045p (28.57%)	94.22M
IMCImc Exploration Group Plc	0.55p (-18.52%)	1.18M
STBSecure Trust Bank Plc	484.00p (-14.49%)	1.1M
DELTDeltic Energy Plc	5.75p (-14.18%)	2.42M
JOGJersey Oil And Gas Plc	63.50p (-12.41%)	192.12k
SAASMicrolise Group Plc	116.50p (-11.07%)	132.63k
NTVONativo Resources Plc	0.0025p (0.00%)	1.25B
DGIDg Innovate Plc	0.0675p (11.57%)	538.38M
TRPTower Resources Plc	0.0305p (0.00%)	523.21M
CPXCap-xx Limited	0.13p (-3.70%)	463.95M
MSMNMosman Oil And Gas Limited	0.0375p (-1.32%)	337.85M